Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

Singapore solar PV capacity to reach 5.3GW by 2035, forecasts GlobalData

Singapore’s power system is shaped by long-standing structural constraints related to land availability, limited domestic energy resources, and rising electricity demand from cooling, electrification, and digital infrastructure. As a net energy importer with no interconnection-free alternatives, Singapore’s energy strategy is guided by the government’s “Four Switches” framework, which combines natural gas, solar PV, regional power […]
Read more

Hong Kong card payments to rise 4.5% in 2025, forecasts GlobalData

The Hong Kong (China SAR) payment card market is mature, yet the total card payment value is forecast to grow by 4.5% in 2025 to reach HKD1.32 trillion ($168.4 billion), supported by the ongoing efforts to promote electronic payments and the steady build-out of acceptance infrastructure, according to GlobalData, a leading intelligence and productivity platform. […]
Read more

Enterprise ICT market revenue in Australia to register healthy 12.9% CAGR over 2024-2029, forecasts GlobalData

Australia’s enterprise ICT market is set to increase at a compound annual growth rate (CAGR) of 12.9% between 2024 and 2029, driven by the enterprise digital transformation programs with growing adoption of technologies like cloud, artificial intelligence (AI), IoT and cybersecurity solutions, and the government’s push for digitalization, according to GlobalData, a leading intelligence and […]
Read more

Ambitions reassessed as oil and gas industry slows pace of energy transition, says GlobalData

The oil and gas industry enters 2026 facing a marked change in momentum regarding the energy transition. Despite recurring climate-related catastrophes—such as record-breaking wildfires, extreme heatwaves—and ongoing calls for emission reductions, the pace of the global energy transition is faltering. Energy-related CO₂ emissions continue to reach new highs, underscoring the persistent dominance of fossil fuels […]
Read more

2025 corporate turning points: capital discipline, AI scale-up and tariff-driven rebalancing set the agenda for 2026, says GlobalData

Corporate strategy in 2025 reached a clear inflection point as companies shifted from expansion-led playbooks to a defensibility-first approach, prioritizing resilience, execution, and policy-aware capital allocation, according to GlobalData, a leading intelligence and productivity platform. GlobalData analysis finds that corporate activity in 2025 converged around three board-level priorities: (i) capital discipline amid tighter financing conditions, (ii) […]
Read more

Thailand card payments to rise by 2.7% in 2025, forecasts GlobalData

Thailand’s total card payments market is forecast to grow by 2.7% in 2025 to reach THB2.3 trillion ($65.4 billion), supported by the expansion of payment acceptance infrastructure, government-led financial inclusion initiatives, and the increasing adoption of contactless payments, according to GlobalData, a leading intelligence and productivity platform. GlobalData’s Payment Cards Analytics reveals that the total […]
Read more

India venture capital momentum defies global funding headwinds in 2025, reveals GlobalData

India’s venture capital (VC) market strengthened its global standing in 2025, recording year-on-year (YoY) double-digit growth in both deal volumes and values during January-November despite persistent volatility across major economies. The divergence from declining trends in other key markets signals rising investor conviction in India’s startup fundamentals, positioning the country as a strategic destination for […]
Read more

Mexico solar PV capacity to reach 37.8GW by 2035, forecasts GlobalData

Mexico’s power and energy sector is undergoing a period of structural realignment under President Claudia Sheinbaum’s administration, shaped by rising electricity demand, renewed regulatory reforms, and a stronger emphasis on energy sovereignty. The updated policy framework reinforces the role of the Federal Electricity Commission (CFE) as the core market participant while enabling selective private investment […]
Read more

Patent cliff looms over global pharma industry, says GlobalData

The pharmaceutical industry is set to face a significant patent cliff over the coming years as several blockbuster drugs lose market exclusivity, increasing exposure to biosimilar and generic competition. This wave is expected to create substantial revenue and pricing pressures across the industry, according to  GlobalData, a leading intelligence and productivity platform. GlobalData’s latest report, […]
Read more

AI remains the most impactful technology in the pharmaceutical sector, says GlobalData

Artificial intelligence (AI) continues to rapidly reshape the global pharmaceutical landscape, as companies look to embed it across research, development and commercialization. As the industry faces mounting pressure to improve efficiency, reduce costs, and deliver better patient outcomes, AI-driven technologies are becoming essential tools to maintain competitiveness and accelerate transformation across the pharmaceutical value chain, […]
Read more

AI-driven digital workplaces set to accelerate in 2026, says GlobalData

Artificial intelligence (AI) dominated digital workplaces in 2025, fuelling trends such as rising adoption of agentic AI, increased platform interoperability, expansion of contact centers, greater support for sales teams, and growing popularity of mobile solutions. Those trends will accelerate in 2026 making it an intriguing year, says GlobalData, a leading intelligence and productivity platform. Gregg […]
Read more

China’s biopharma ascent signals structural shift in global drug development leadership, says GlobalData

China’s rise as a biopharma innovator is reshaping global drug development, underpinned by regulatory reform and a rapidly deepening pipeline. Now accounting for one-fifth of drugs in development worldwide, China has overtaken Europe and moved beyond “me-too” models. Its growing strength across advanced biologics signals a structural shift global pharma can no longer ignore across […]
Read more

Vulnerable UK customers consider insurance application too time-consuming, finds GlobalData

Many vulnerable customers cite challenges with the insurance application process, while a significant proportion are denied a policy altogether. Some are left feeling uneasy and judged about the insurance application process, suggesting the industry has some way to go to improve processes, reveals a survey by GlobalData, a leading intelligence and productivity platform. According to […]
Read more

Global macroeconomic round-up 2025 and what to watch out for in 2026: a data-led view for business leaders by GlobalData

As 2025 progressed, the global economy had largely moved beyond post-COVID distortions, but growth remained uneven and the path into 2026 looks fragile. A comparatively strong first half of 2025, helped by companies advancing imports, swift supply-chain reconfiguration, and targeted fiscal support, gave way to softer momentum as tighter financial conditions and elevated policy uncertainty […]
Read more

Global wind turbines market to reach an aggregate installation of 934.6GW in 2030, forecasts GlobalData

The global wind‑energy market is entering its strongest growth phase to date, driven by accelerating national decarbonization targets, energy‑security needs and long‑term industrial strategies. The aggregate installations are expected to reach 934.6GW in 2030, forecasts  GlobalData, a leading intelligence and productivity platform. GlobalData’s latest report, “Wind Turbines Market Size, Share and Trends Analysis by Technology, […]
Read more

China VC funding value down 30% YoY during January-November 2025 even as deal volume grows, finds GlobalData

China venture capital (VC) funding landscape has experienced a significant decline in deal value, despite showcasing resilience in terms of volume. The total number of VC deals announced in China increased by 8% during January-November 2025 compared to the same period in the previous year whereas the corresponding funding value fell by around 30% year-on-year […]
Read more

PCSK9 approval marks shift to long-acting LDL-C control in high-risk cardiovascular patients, says GlobalData

Once monthly proprotein convertase subtilisin/kexin type 9 (PCSK9) therapy has moved into a new phase with FDA approval of LIB Therapeutics’ Lerochol for adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia (HeFH). The approval highlights a clear industry shift toward long-acting, adherence-focused lipid-lowering options as payers, clinicians, and innovators prioritize sustained LDL-C control in high-risk cardiovascular […]
Read more
1 … 26 27 28 29 30 … 770